These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14672715)

  • 1. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy.
    Hayashi T; Arimura T; Ueda K; Shibata H; Hohda S; Takahashi M; Hori H; Koga Y; Oka N; Imaizumi T; Yasunami M; Kimura A
    Biochem Biophys Res Commun; 2004 Jan; 313(1):178-84. PubMed ID: 14672715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
    Sotgia F; Woodman SE; Bonuccelli G; Capozza F; Minetti C; Scherer PE; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1150-60. PubMed ID: 12839838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
    Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
    J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
    Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF
    Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
    Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C
    Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
    Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
    J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
    Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
    Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolae and caveolin-3 in muscular dystrophy.
    Galbiati F; Razani B; Lisanti MP
    Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
    Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy.
    Müller JS; Piko H; Schoser BG; Schlotter-Weigel B; Reilich P; Gürster S; Born C; Karcagi V; Pongratz D; Lochmüller H; Walter MC
    Neuromuscul Disord; 2006 Jul; 16(7):432-6. PubMed ID: 16730439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel CAV3 gene mutations in Japanese families.
    Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
    Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the caveolin-3 gene: When are they pathogenic?
    de Paula F; Vainzof M; Bernardino AL; McNally E; Kunkel LM; Zatz M
    Am J Med Genet; 2001 Apr; 99(4):303-7. PubMed ID: 11251997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
    Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
    Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
    Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Caveolin-3 P104L mutation of LGMD-1C leads to disordered glucose metabolism in muscle cells.
    Deng YF; Huang YY; Lu WS; Huang YH; Xian J; Wei HQ; Huang Q
    Biochem Biophys Res Commun; 2017 Apr; 486(2):218-223. PubMed ID: 28232187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia.
    Carbone I; Bruno C; Sotgia F; Bado M; Broda P; Masetti E; Panella A; Zara F; Bricarelli FD; Cordone G; Lisanti MP; Minetti C
    Neurology; 2000 Mar; 54(6):1373-6. PubMed ID: 10746614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
    Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
    Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of fukutin gene in dilated cardiomyopathy and hypertrophic cardiomyopathy.
    Arimura T; Hayashi YK; Murakami T; Oya Y; Funabe S; Arikawa-Hirasawa E; Hattori N; Nishino I; Kimura A
    Circ J; 2009 Jan; 73(1):158-61. PubMed ID: 19015585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.